Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors

Details for Australian Patent Application No. 2009296045 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Gobbi, Luca; Jaeschke, Georg; Rodriguez Sarmiento, Rosa Maria; Steward, Lucinda

Agent Spruson & Ferguson

Pub. Number AU-A-2009296045

PCT Pub. Number WO2010/034646

Priority 08164903.0 23.09.08 EP

Filing date 15 September 2009

Wipo publication date 1 April 2010

International Classifications

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 April 2011 PCT application entered the National Phase

  PCT publication WO2010/034646 Priority application(s): WO2010/034646

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009296047-Pyridinylpiperazin derivatives useful as modulators of dopamine D3 receptors

2009296041-Reducing astringency in compositions containing phenolic compounds